FibroBiologics Inc. Common Stock

FBLG | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.37

+$0.01 (+0.74%)

Sep 22, 2026, 1:57 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.85M

Enterprise Value $673.52K

Beta 1.22

Average Volume 245.59K

Shares Outstanding (Diluted) 6.27M

Shares Change YoY 224.71%

Institutional Ownership 5.85%

Exchange NASDAQ

ISIN US31573L2043

Price Performance

Price Change 1M -3.5%

Price Change 3M 81.3%

Price Change 6M -74.2%

Price Change YTD -71.7%

Price Change 1Y -87.1%

Price Change 3Y -99.5%

Price Change 5Y -99.5%

1M CAGR (ann.) 39.3%

1Y CAGR (ann.) -87.3%

5Y CAGR (ann.) N/A

All-Time CAGR N/A

Valuation

PE Ratio -0.21

Forward PE N/A

PEG Ratio 0.32

Forward PEG -0.03

PS Ratio N/A

Forward PS N/A

PB Ratio 0.61

P/FCF Ratio -0.19

P/Adj. FCF Ratio -0.16

P/OCF Ratio -0.35

EV/Sales N/A

EV/EBIT -0.05

EV/EBITDA -0.04

EV/FCF -0.05

Earnings Yield -476.5%

FCF Yield -519.1%

Adj. FCF Yield -617.5%

Financial Health

Net Cash $2.18M

Total Debt $1.34M

Cash & Short-Term Investments $3.52M

Total Assets $7.93M

Current Ratio 2.64

Quick Ratio 2.64

Debt / Equity Ratio 0.32

Debt / EBITDA -0.08

Debt / FCF -0.09

OCF / Debt -11.05

Interest Coverage -77.81

Altman Z-Score -15.85

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -19.0%

Returns

Return on Assets -228.8%

Return on Equity -536.8%

Return on Invested Capital -274.3%

Return on Capital Employed -292.7%

Return on Tangible Assets -228.8%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 33.9%

EPS CAGR 5Y -29.6%

EPS CAGR 10Y N/A

FCF CAGR 3Y -20.3%

FCF CAGR 5Y -46.8%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 4

EPS Growth Next 3Y 8.2%

Revenue Growth Next 3Y N/A

Earnings Date Oct 29, 2026

EPS Estimate (next Q) -$0.63

EPS Growth Est (next Q) -75.8%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $180

Price Target Upside 13135.3%

Cash Flow

Operating Cash Flow $-14.79M

Free Cash Flow $-14.8M

Adj. Free Cash Flow $-17.6M

FCF Per Share -$3.92

OCF Per Share -$3.92

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-234K

Operating Income $-16.73M

EBITDA $-17.15M

Net Income $-18.14M

EPS (Diluted) -$6.48

Revenue / Employee N/A

Profit / Employee $-1.21M

Employees 15